Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Thorax. 2020 Aug 31;75(10):849–854. doi: 10.1136/thoraxjnl-2020-214875

Table 2.

Multivariable analysis of serum free testosterone level and current wheeze and at least one asthma hospitalization

Serum levels of sex hormones Current wheeze At least one asthma
hospitalization
Odds ratio (95% confidence interval)
Women with asthma (n=14,056) n=8,826 n=484
Quartiles (Q) of free testosterone, pmol/L
   Q1 (< 5.9) 1.0 1.0
   Q2 (5.9- < 9.8) 0.87 (0.79, 0.96) 0.91 (0.71, 1.17)
   Q3 (9.8- < 14.8) 0.78 (0.70, 0.86) 0.86 (0.66, 1.11)
   Q4 (≥ 14.8) 0.78 (0.71, 0.87) 0.73 (0.56, 0.95)*
  Estradiol, pmol/L
   < 123.7 1.0 1.0
   ≥ 123.7 1.10 (0.99-1.22) 1.12 (0.86, 1.45)
Men with asthma (n=14,247) n=9,341 n=354
  Quartiles (Q) of free testosterone, pmol/L
   Q1 (< 121.0) 1.0 1.0
   Q2 (121.0- < 158.5) 1.01 (0.91, 1.12) 0.91 (0.67, 1.22)
   Q3 (158.5- < 199.2) 0.93 (0.84, 1.03) 0.86 (0.64, 1.17)
   Q4 (≥ 199.2) 0.86 (0.77, 0.95) 0.84 (0.61, 1.15)
  Estradiol, pmol/L
   < 123.7 1.0 1.0
   ≥ 123.7 0.96 (0.84, 1.08) 1.20 (0.85, 1.70)

All models included both serum free testosterone and serum estradiol levels, and were adjusted for age, race/ethnicity, annual household income, body mass index, smoking status, pack-years of smoking, current use of birth control pills or hormone replacement therapy and menopause status (in women), and the season and the time of the day when the examination was performed.

*

P<0.05

P<0.01

P for trend < 0.05